Patrick Hurban, Ph.D. | January 13, 2016

Precision Medicine – Leveraging Genomics in Clinical Research

Part one
In part one of a three-part video series, Patrick Hurban, Ph.D., senior director and global head, Genomic Development/Esoteric Assays at Q2 Solutions, discusses the significance of genomic technologies in clinical trials.

Watch Dr. Hurban share his perspective on genomic technologies and the future of precision medicine as well as how both will impact healthcare globally.

Related Services:
Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More